Effective active learning in digital pathology: A case study in tumor infiltrating lymphocytes
Related Experiment Video
Updated: Sep 24, 2025

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model
Published on: April 13, 2015
André Ls Meirelles1, Tahsin Kurc2, Joel Saltz2
1Department of Computer Science, University of Brasília, Brasília, 70910-900, Brazil.
Background And Objective:
Deep learning methods have demonstrated remarkable performance in pathology image analysis, but they require a large amount of annotated training data from expert pathologists. The aim of this study is to minimize the data annotation need in these analyses.
Methods:
Active learning (AL) is an iterative approach to training deep learning models. It was used in our context with a Tumor Infiltrating Lymphocytes (TIL) classification task to minimize annotation. State-of-the-art AL methods were evaluated with the TIL application and we have proposed and evaluated a more efficient and effective AL acquisition method. The proposed method uses data grouping based on imaging features and model prediction uncertainty to select meaningful training samples (image patches).
Results:
An experimental evaluation with a collection of cancer tissue images shows that: (i) Our approach reduces the number of patches required to attain a given AUC as compared to other approaches, and (ii) our optimization (subpooling) leads to AL execution time improvement of about 2.12×.
Conclusions:
This strategy enabled TIL based deep learning analyses using smaller annotation demand. We expect this approach may be used to build other analyses in digital pathology with fewer training samples.
More Related Videos
06:05Author Spotlight: Multiplex Immunofluorescence Combined with Spatial Image Analysis for the Clinical and Biological Assessment of the Tumor Microenvironment
Published on: June 2, 2023
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024